UniProt ID | TCEA1_HUMAN | |
---|---|---|
UniProt AC | P23193 | |
Protein Name | Transcription elongation factor A protein 1 | |
Gene Name | TCEA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 301 | |
Subcellular Localization | Nucleus. | |
Protein Description | Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus.. | |
Protein Sequence | MEDEVVRFAKKMDKMVQKKNAAGALDLLKELKNIPMTLELLQSTRIGMSVNAIRKQSTDEEVTSLAKSLIKSWKKLLDGPSTEKDLDEKKKEPAITSQNSPEAREESTSSGNVSNRKDETNARDTYVSSFPRAPSTSDSVRLKCREMLAAALRTGDDYIAIGADEEELGSQIEEAIYQEIRNTDMKYKNRVRSRISNLKDAKNPNLRKNVLCGNIPPDLFARMTAEEMASDELKEMRKNLTKEAIREHQMAKTGGTQTDLFTCGKCKKKNCTYTQVQTRSADEPMTTFVVCNECGNRWKFC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDEVVRF -------CHHHHHHH | 15.35 | 22814378 | |
19 | 2-Hydroxyisobutyrylation | MDKMVQKKNAAGALD HHHHHHHCCHHHHHH | 34.43 | - | |
19 | Ubiquitination | MDKMVQKKNAAGALD HHHHHHHCCHHHHHH | 34.43 | - | |
22 (in isoform 2) | Phosphorylation | - | 17.12 | 17287340 | |
28 (in isoform 2) | Phosphorylation | - | 3.96 | 17287340 | |
29 | 2-Hydroxyisobutyrylation | AGALDLLKELKNIPM HHHHHHHHHHCCCCC | 69.19 | - | |
29 | Acetylation | AGALDLLKELKNIPM HHHHHHHHHHCCCCC | 69.19 | 27452117 | |
29 (in isoform 1) | Ubiquitination | - | 69.19 | 21890473 | |
29 | Ubiquitination | AGALDLLKELKNIPM HHHHHHHHHHCCCCC | 69.19 | 21890473 | |
36 (in isoform 2) | Phosphorylation | - | 6.22 | 29116813 | |
46 (in isoform 2) | Ubiquitination | - | 5.71 | 21890473 | |
47 (in isoform 2) | Phosphorylation | - | 10.06 | 17287340 | |
48 | Sulfoxidation | LQSTRIGMSVNAIRK HHHCCCCCCHHHHHH | 3.63 | 21406390 | |
49 | Phosphorylation | QSTRIGMSVNAIRKQ HHCCCCCCHHHHHHC | 13.65 | - | |
57 | Phosphorylation | VNAIRKQSTDEEVTS HHHHHHCCCHHHHHH | 40.64 | 27273156 | |
58 | Phosphorylation | NAIRKQSTDEEVTSL HHHHHCCCHHHHHHH | 44.96 | 26657352 | |
63 | Phosphorylation | QSTDEEVTSLAKSLI CCCHHHHHHHHHHHH | 22.69 | 23312004 | |
64 | Phosphorylation | STDEEVTSLAKSLIK CCHHHHHHHHHHHHH | 31.35 | 23312004 | |
67 | Ubiquitination | EEVTSLAKSLIKSWK HHHHHHHHHHHHHHH | 51.60 | 21890473 | |
67 (in isoform 1) | Ubiquitination | - | 51.60 | 21890473 | |
68 | Phosphorylation | EVTSLAKSLIKSWKK HHHHHHHHHHHHHHH | 29.71 | 21712546 | |
75 | Malonylation | SLIKSWKKLLDGPST HHHHHHHHHHCCCCC | 48.28 | 26320211 | |
75 | Ubiquitination | SLIKSWKKLLDGPST HHHHHHHHHHCCCCC | 48.28 | - | |
81 | Phosphorylation | KKLLDGPSTEKDLDE HHHHCCCCCHHCHHH | 55.52 | 30266825 | |
82 | Phosphorylation | KLLDGPSTEKDLDEK HHHCCCCCHHCHHHH | 50.62 | 30266825 | |
84 | Acetylation | LDGPSTEKDLDEKKK HCCCCCHHCHHHHHH | 64.77 | 23954790 | |
84 | Succinylation | LDGPSTEKDLDEKKK HCCCCCHHCHHHHHH | 64.77 | 23954790 | |
84 | Ubiquitination | LDGPSTEKDLDEKKK HCCCCCHHCHHHHHH | 64.77 | 19608861 | |
96 | Phosphorylation | KKKEPAITSQNSPEA HHHCCCCCCCCCHHH | 26.77 | 20201521 | |
97 | Phosphorylation | KKEPAITSQNSPEAR HHCCCCCCCCCHHHH | 22.66 | 20201521 | |
100 | Phosphorylation | PAITSQNSPEAREES CCCCCCCCHHHHHHH | 19.24 | 19664994 | |
107 | Phosphorylation | SPEAREESTSSGNVS CHHHHHHHCCCCCCC | 28.92 | 24732914 | |
108 | Phosphorylation | PEAREESTSSGNVSN HHHHHHHCCCCCCCC | 30.14 | 23927012 | |
109 | Phosphorylation | EAREESTSSGNVSNR HHHHHHCCCCCCCCC | 45.59 | 24732914 | |
110 | Phosphorylation | AREESTSSGNVSNRK HHHHHCCCCCCCCCC | 34.18 | 25159151 | |
114 | Phosphorylation | STSSGNVSNRKDETN HCCCCCCCCCCCCCC | 34.61 | 24732914 | |
120 | Phosphorylation | VSNRKDETNARDTYV CCCCCCCCCCCHHCH | 44.29 | 23828894 | |
125 | Phosphorylation | DETNARDTYVSSFPR CCCCCCHHCHHCCCC | 21.92 | 28442448 | |
126 | Phosphorylation | ETNARDTYVSSFPRA CCCCCHHCHHCCCCC | 11.56 | 25159151 | |
126 | Nitration | ETNARDTYVSSFPRA CCCCCHHCHHCCCCC | 11.56 | - | |
128 | Phosphorylation | NARDTYVSSFPRAPS CCCHHCHHCCCCCCC | 18.82 | 28634120 | |
129 | Phosphorylation | ARDTYVSSFPRAPST CCHHCHHCCCCCCCC | 29.26 | 28450419 | |
135 | Phosphorylation | SSFPRAPSTSDSVRL HCCCCCCCCCHHHHH | 39.29 | 25159151 | |
136 | Phosphorylation | SFPRAPSTSDSVRLK CCCCCCCCCHHHHHH | 35.18 | 25262027 | |
137 | Phosphorylation | FPRAPSTSDSVRLKC CCCCCCCCHHHHHHH | 32.02 | 25262027 | |
139 | Phosphorylation | RAPSTSDSVRLKCRE CCCCCCHHHHHHHHH | 14.65 | 28450419 | |
170 | Phosphorylation | ADEEELGSQIEEAIY CCHHHHHHHHHHHHH | 40.38 | 25338102 | |
177 | Phosphorylation | SQIEEAIYQEIRNTD HHHHHHHHHHHHCCC | 13.72 | 27642862 | |
186 | Acetylation | EIRNTDMKYKNRVRS HHHCCCHHHHHHHHH | 56.75 | 25953088 | |
196 | Phosphorylation | NRVRSRISNLKDAKN HHHHHHHHCCCCCCC | 34.69 | 28787133 | |
199 | Succinylation | RSRISNLKDAKNPNL HHHHHCCCCCCCCCC | 60.95 | 23954790 | |
199 | Acetylation | RSRISNLKDAKNPNL HHHHHCCCCCCCCCC | 60.95 | 23749302 | |
202 | Ubiquitination | ISNLKDAKNPNLRKN HHCCCCCCCCCCCCC | 80.98 | - | |
223 | Sulfoxidation | PPDLFARMTAEEMAS CHHHHHHHCHHHHCH | 3.60 | 21406390 | |
224 | Phosphorylation | PDLFARMTAEEMASD HHHHHHHCHHHHCHH | 25.93 | 30624053 | |
230 | Phosphorylation | MTAEEMASDELKEMR HCHHHHCHHHHHHHH | 30.24 | 28258704 | |
234 | Ubiquitination | EMASDELKEMRKNLT HHCHHHHHHHHHHHH | 47.63 | - | |
242 | Methylation | EMRKNLTKEAIREHQ HHHHHHHHHHHHHHH | 48.60 | 54424997 | |
242 | Ubiquitination | EMRKNLTKEAIREHQ HHHHHHHHHHHHHHH | 48.60 | - | |
252 | Acetylation | IREHQMAKTGGTQTD HHHHHHHHCCCCCCC | 42.22 | 25953088 | |
252 | Ubiquitination | IREHQMAKTGGTQTD HHHHHHHHCCCCCCC | 42.22 | - | |
253 | Phosphorylation | REHQMAKTGGTQTDL HHHHHHHCCCCCCCC | 31.16 | 28555341 | |
262 | Phosphorylation | GTQTDLFTCGKCKKK CCCCCCEECCCCCCC | 27.87 | 25159151 | |
265 | Ubiquitination | TDLFTCGKCKKKNCT CCCEECCCCCCCCCE | 45.06 | - | |
265 | Acetylation | TDLFTCGKCKKKNCT CCCEECCCCCCCCCE | 45.06 | 25953088 | |
267 | Ubiquitination | LFTCGKCKKKNCTYT CEECCCCCCCCCEEE | 70.98 | - | |
272 | Phosphorylation | KCKKKNCTYTQVQTR CCCCCCCEEEEEECC | 38.71 | 28796482 | |
273 | Phosphorylation | CKKKNCTYTQVQTRS CCCCCCEEEEEECCC | 9.44 | 28796482 | |
273 | Nitration | CKKKNCTYTQVQTRS CCCCCCEEEEEECCC | 9.44 | - | |
274 | Phosphorylation | KKKNCTYTQVQTRSA CCCCCEEEEEECCCC | 12.24 | 28796482 | |
278 | Phosphorylation | CTYTQVQTRSADEPM CEEEEEECCCCCCCC | 27.95 | 28152594 | |
285 | Sulfoxidation | TRSADEPMTTFVVCN CCCCCCCCEEEEEEC | 5.33 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TCEA1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCEA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCEA1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-97 AND SER-100, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-84, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-97 AND SER-100, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-100, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81; SER-100; THR-108;SER-110 AND TYR-126, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-96, AND MASSSPECTROMETRY. |